UVFT Stock Overview

Engages in the research, development, manufacture, and sale of air purification systems and products primarily in the United States. More details

UVFT fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Does not have a meaningful market cap ($13K)

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

UV Flu Technologies, Inc. Competitors

EESTech

OTCPK:EESH

US$118.6k

Future Mobility Solutions

OTCPK:SLFF.F

US$28.3k

voxeljet

OTCPK:VJTT.Y

US$338.0k

Quality Industrial

OTCPK:QIND

US$2.7m

Price History & Performance

Summary of share price highs, lows and changes for UV Flu Technologies
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.0002
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	0%
3 Year Change	0%
5 Year Change	-98.00%
Change since IPO	-99.99%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	UVFT	US Machinery	US Market
7D	0%	0.5%	1.2%
1Y	0%	12.2%	21.0%

Return vs Industry: UVFT underperformed the US Machinery industry which returned 12.5% over the past year.

Return vs Market: UVFT underperformed the US Market which returned 20.2% over the past year.

Price Volatility

Is UVFT's price volatile compared to industry and market?
UVFT volatility
UVFT Average Weekly Movement	n/a
Machinery Industry Average Movement	4.9%
Market Average Movement	6.0%
10% most volatile stocks in US Market	18.5%
10% least volatile stocks in US Market	3.0%

Stable Share Price: UVFT's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine UVFT's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2006	n/a	Michael Ross	www.uvflutech.com

UV Flu Technologies, Inc. engages in the research, development, manufacture, and sale of air purification systems and products primarily in the United States. Its flagship product is the ViraTech UV-400, which utilizes high-intensity germicidal ultraviolet radiation inside a killing chamber that goes beyond filtering to trap and destroy harmful microbes. The company also offers RX Air product line, which include HEPA based air purifiers.

UV Flu Technologies, Inc. Fundamentals Summary

How do UV Flu Technologies's earnings and revenue compare to its market cap?
UVFT fundamental statistics
Market cap	US$13.42k
Earnings (TTM)	-US$750.44k
Revenue (TTM)	US$194.75k

0.0x

P/S Ratio

0.0x

P/E Ratio

Is UVFT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
UVFT income statement (TTM)
Revenue	US$194.75k
Cost of Revenue	US$145.19k
Gross Profit	US$49.55k
Other Expenses	US$800.00k
Earnings	-US$750.44k

Last Reported Earnings

Mar 31, 2016

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did UVFT perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/11 05:12
End of Day Share Price	2025/01/31 00:00
Earnings	2016/03/31
Annual Earnings	2015/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

UV Flu Technologies, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.